The British antibiotic and silver-impregnated catheters for ventriculoperitoneal shunts multi-centre randomised controlled trial (the BASICS trial): Study protocol

Trials

Volumn 15, Issue 1, 2014, Pages

  Jenkinson, Michael D ^a,b   Gamble, Carrol ^b   Hartley, John C ^c   Hickey, Helen ^b   Hughes, Dyfrig ^d   Blundell, Michaela ^b   Griffiths, Michael J ^b,e   Solomon, Tom ^a,b   Mallucci, Conor L ^b,e  

^a THE WALTON CENTRE NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^d BANGOR UNIVERSITY   (United Kingdom)

^e ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Antibiotic impregnated; Clinical trial; Infection; Silver impregnated; Ventriculoperitoneal shunt

Indexed keywords

CLINDAMYCIN; RIFAMPICIN;

ANTIBIOTIC IMPREGNATED; ANTIMICROBIAL CATHETER; ARTICLE; BRAIN VENTRICLE PERITONEUM SHUNT; CATHETER INFECTION; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; FOLLOW UP; HEALTH CARE COST; HUMAN; HYDROCEPHALUS; INFECTION RATE; LENGTH OF STAY; MEDICAL DEVICE COMPLICATION; MULTICENTER STUDY (TOPIC); NEUROENDOSCOPY; PERITONITIS; PHASE 3 CLINICAL TRIAL (TOPIC); QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SHUNT INFECTION; SILVER IMPREGNATED CATHETER; TREATMENT OUTCOME; VENTRICULOATRIAL SHUNT;

ANTI-BACTERIAL AGENTS; CATHETER-RELATED INFECTIONS; CATHETERS; COATED MATERIALS, BIOCOMPATIBLE; COST SAVINGS; COST-BENEFIT ANALYSIS; DRUG RESISTANCE, BACTERIAL; EQUIPMENT DESIGN; EQUIPMENT FAILURE; GREAT BRITAIN; HEALTH CARE COSTS; HUMANS; HYDROCEPHALUS; SILVER; TIME FACTORS; TREATMENT OUTCOME; VENTRICULOPERITONEAL SHUNT;

EID: 84891750969     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-15-4     Document Type: Article

References (32)

1. Richards HK, Seeley HM, Pickard JD. Efficacy of antibiotic-impregnated shunt catheters in reducing shunt infection: data from the United Kingdom Shunt Registry. J Neurosurg Pediatr 2009, 4(4):389-393. 10.3171/2009.4.PEDS09210, 19795972.
2. Borgbjerg BM, Gjerris F, Albeck MJ, Børgesen SE. Risk of infection after cerebrospinal fluid shunt: an analysis of 884 first-time shunts. Acta Neurochir (Wien) 1995, 136(1-2):1-7.
3. Choux M, Genitori L, Lang D, Lena G. Shunt implantation: reducing the incidence of shunt infection. J Neurosurg 1992, 77(6):875-880. 10.3171/jns.1992.77.6.0875, 1432129.
4. Enger P, Svendsen F, Wester K. CSF shunt infections in children: experiences from a population-based study. Acta Neurochir (Wien) 2003, 145(4):243-248. discussion 248, 10.1007/s00701-002-1068-5, 12748883.
5. Pople IK, Bayston R, Hayward RD. Infection of cerebrospinal fluid shunts in infants: a study of etiological factors. J Neurosurg 1992, 77(1):29-36. 10.3171/jns.1992.77.1.0029, 1607969.
6. Ronan A, Hogg GG, Klug GL. Cerebrospinal fluid shunt infections in children. Pediatr Infect Dis J 1995, 14(9):782-786. 10.1097/00006454-199509000-00010, 8559628.
7. Vinchon M, Dhellemmes P. Cerebrospinal fluid shunt infection: risk factors and long-term follow-up. Childs Nerv Syst 2006, 22(7):692-697. 10.1007/s00381-005-0037-8, 16534646.
8. Schreffler RT, Schreffler AJ, Wittler RR. Treatment of cerebrospinal fluid shunt infections: a decision analysis. Pediatr Infect Dis J 2002, 21(7):632-636. 10.1097/00006454-200207000-00006, 12237594.
9. Thomas R, Lee S, Patole S, Rao S. Antibiotic-impregnated catheters for the prevention of CSF shunt infections: a systematic review and meta-analysis. Br J Neurosurg 2012, 26(2):175-184. 10.3109/02688697.2011.603856, 21973061.
10. Hayhurst C, Cooke R, Williams D, Kandasamy J, O'Brien DF, Mallucci CL. The impact of antibiotic-impregnated catheters on shunt infection in children and neonates. Childs Nerv Syst 2008, 24(5):557-562. 10.1007/s00381-007-0521-4, 17962953.
11. Kandasamy J, Dwan K, Hartley JC, Jenkinson MD, Hayhurst C, Gatscher S, Thompson D, Crimmins D, Mallucci C. Antibiotic-impregnated ventriculoperitoneal shunts-a multi-centre British paediatric neurosurgery group (BPNG) study using historical controls. Childs Nerv Syst 2011, 27(4):575-581. 10.1007/s00381-010-1290-z, 20953871.
12. Izci Y, Secer H, Akay C, Gonul E. Initial experience with silver-impregnated polyurethane ventricular catheter for shunting of cerebrospinal fluid in patients with infected hydrocephalus. Neurol Res 2009, 31(3):234-237. 10.1179/174313209X380973, 19040800.
13. Keong NC, Bulters DO, Richards HK, Farrington M, Sparrow OC, Pickard JD, Hutchinson PJ, Kirkpatrick PJ. The SILVER (silver impregnated line versus EVD randomized trial): a double-blind, prospective, randomized, controlled trial of an intervention to reduce the rate of external ventricular drain infection. Neurosurgery 2012, 71(2):394-403. discussion 403-404, 10.1227/NEU.0b013e318257bebb, 22811084.
14. Fichtner J, Güresir E, Seifert V, Raabe A. Efficacy of silver-bearing external ventricular drainage catheters: a retrospective analysis. J Neurosurg 2010, 112(4):840-846. 10.3171/2009.8.JNS091297, 19764827.
15. Lackner P, Beer R, Broessner G, Helbok R, Galiano K, Pleifer C, Pfausler B, Brenneis C, Huck C, Engelhardt K, Obwegeser AA, Schmutzhard E. Efficacy of silver nanoparticles-impregnated external ventricular drain catheters in patients with acute occlusive hydrocephalus. Neurocrit Care 2008, 8(3):360-365. 10.1007/s12028-008-9071-1, 18320144.
16. Richards H. The UK Shunt Registry. Cerebrospinal Fluid Disorders 2010, 494-495. New York: Informa Healthcare, Mallucci CL, Sgouros S.
17. Drake JM, Kestle JR, Milner R, Cinalli G, Boop F, Piatt J, Haines S, Schiff SJ, Cochrane DD, Steinbok P, MacNeil N. Randomized trial of cerebrospinal fluid shunt valve design in pediatric hydrocephalus. Neurosurgery 1998, 43(2):294-303. discussion 303-305, 10.1097/00006123-199808000-00068, 9696082.
18. Demetriades AK, Bassi S. Antibiotic resistant infections with antibiotic-impregnated bactiseal catheters for ventriculoperitoneal shunts. Br J Neurosurg 2011, 25(6):671-673. 10.3109/02688697.2011.575478, 21707238.
19. Morgan RD, Hartley J, Jeelani ON, Thompson D, Harkness W, Hayward R, Ternier J. What are the long term impacts of antibiotic-impregnated shunts (AIS) on shunt infection?. Br J Neurosurg 2011, 25(2):152-153.
20. Attenello FJ, Garces-Ambrossi GL, Zaidi HA, Sciubba DM, Jallo GI. Hospital costs associated with shunt infections in patients receiving antibiotic-impregnated shunt catheters versus standard shunt catheters. Neurosurgery 2010, 66(2):284-289. discussion 289, 10.1227/01.NEU.0000363405.12584.4D, 20087127.
21. Eymann R, Chehab S, Strowitzki M, Steudel WI, Kiefer M. Clinical and economic consequences of antibiotic-impregnated cerebrospinal fluid shunt catheters. J Neurosurg Pediatr 2008, 1(6):444-450. 10.3171/PED/2008/1/6/444, 18518694.
22. Farber SH, Parker SL, Adogwa O, Rigamonti D, McGirt MJ. Cost analysis of antibiotic-impregnated catheters in the treatment of hydrocephalus in adult patients. World Neurosurg 2010, 74(4-5):528-531.
23. Sciubba DM, Lin LM, Woodworth GF, McGirt MJ, Carson B, Jallo GI. Factors contributing to the medical costs of cerebrospinal fluid shunt infection treatment in pediatric patients with standard shunt components compared with those in patients with antibiotic impregnated components. Neurosurg Focus 2007, 22(4):E9.
24. Pintilie M. Dealing with competing risks: testing covariates and calculating sample size. Stat Med 2002, 21(22):3317-3324. 10.1002/sim.1271, 12407674.
25. Fine PF, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999, 94:496-509.
26. Scheike TH, Zhang MJ. Flexible competing risks regression modeling and goodness-of-fit. Lifetime Data Anal 2008, 14(4):464-483. 10.1007/s10985-008-9094-0, 2715961, 18752067.
27. Haybittle JL. Repeated assessment of results in clinical trials of cancer treatment. Br J Radiol 1971, 44(526):793-797. 10.1259/0007-1285-44-526-793, 4940475.
28. Ridyard CH, Hughes DA. Methods for the collection of resource use data within clinical trials: a systematic review of studies funded by the UK health technology assessment program. Value Health 2010, 13(8):867-872. 10.1111/j.1524-4733.2010.00788.x, 20946187.
29. Department of Health NHS Reference Costs 2009-2010 2011, London: Department of Health, Department of Health.
30. Joint Formulary Committee British National Formulary (BNF) 61 2011, London: Pharmaceutical Press, Joint Formulary Committee.
31. Curtis L. Unit Costs of Health and Social Care 2010, Canterbury: Personal Social Services Research Unit (PSSRU).
32. Glick HA, Doshi JA, Sonnad SS, Polsky D. Economic Evaluation in Clinical Trials 2007, Oxford: Oxford University Press.